HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
HCA Healthcare Price Performance
Shares of HCA Healthcare stock traded down $7.01 during trading hours on Friday, hitting $338.50. The company’s stock had a trading volume of 320,648 shares, compared to its average volume of 1,179,386. HCA Healthcare, Inc. has a 12-month low of $238.82 and a 12-month high of $417.14. The business has a 50 day moving average price of $386.00 and a two-hundred day moving average price of $357.03. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a market cap of $85.74 billion, a PE ratio of 15.15, a PEG ratio of 1.34 and a beta of 1.68.
HCA Healthcare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.
Institutional Investors Weigh In On HCA Healthcare
Wall Street Analysts Forecast Growth
Several brokerages have commented on HCA. TD Cowen cut their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. KeyCorp dropped their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Barclays lowered their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.
Check Out Our Latest Analysis on HCA
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- Golden Cross Stocks: Pattern, Examples and Charts
- Top-Performing Non-Leveraged ETFs This Year
- What is Short Interest? How to Use It
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- How Investors Can Find the Best Cheap Dividend Stocks
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.